321 related articles for article (PubMed ID: 27157610)
1. A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.
Fessler E; Jansen M; De Sousa E Melo F; Zhao L; Prasetyanti PR; Rodermond H; Kandimalla R; Linnekamp JF; Franitza M; van Hooff SR; de Jong JH; Oppeneer SC; van Noesel CJ; Dekker E; Stassi G; Wang X; Medema JP; Vermeulen L
Oncogene; 2016 Nov; 35(46):6026-6037. PubMed ID: 27157610
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
3. Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer.
Zhao L; Wang W; Xu L; Yi T; Zhao X; Wei Y; Vermeulen L; Goel A; Zhou S; Wang X
Oncogene; 2019 Mar; 38(13):2305-2319. PubMed ID: 30478449
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.
Shi X; Kaller M; Rokavec M; Kirchner T; Horst D; Hermeking H
Cell Mol Gastroenterol Hepatol; 2020; 10(2):391-418. PubMed ID: 32304779
[TBL] [Abstract][Full Text] [Related]
5. Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells.
Ma K; Pan X; Fan P; He Y; Gu J; Wang W; Zhang T; Li Z; Luo X
Mol Cancer; 2014 May; 13():118. PubMed ID: 24885288
[TBL] [Abstract][Full Text] [Related]
6. Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis.
Rokavec M; Bouznad N; Hermeking H
Cell Mol Gastroenterol Hepatol; 2019; 7(4):783-802. PubMed ID: 30831320
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-mRNA interactions underlying colorectal cancer molecular subtypes.
Cantini L; Isella C; Petti C; Picco G; Chiola S; Ficarra E; Caselle M; Medico E
Nat Commun; 2015 Nov; 6():8878. PubMed ID: 27305450
[TBL] [Abstract][Full Text] [Related]
9. Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family.
Song F; Yang D; Liu B; Guo Y; Zheng H; Li L; Wang T; Yu J; Zhao Y; Niu R; Liang H; Winkler H; Zhang W; Hao X; Chen K
Clin Cancer Res; 2014 Feb; 20(4):878-89. PubMed ID: 24352645
[TBL] [Abstract][Full Text] [Related]
10. The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer.
Le Corre D; Ghazi A; Balogoun R; Pilati C; Aparicio T; Martin-Lannerée S; Marisa L; Djouadi F; Poindessous V; Crozet C; Emile JF; Mulot C; Le Malicot K; Boige V; Blons H; de Reynies A; Taieb J; Ghiringhelli F; Bennouna J; Launay JM; Laurent-Puig P; Mouillet-Richard S
EBioMedicine; 2019 Aug; 46():94-104. PubMed ID: 31377347
[TBL] [Abstract][Full Text] [Related]
11. A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.
To KK; Leung WW; Ng SS
Mol Carcinog; 2017 Feb; 56(2):464-477. PubMed ID: 27253631
[TBL] [Abstract][Full Text] [Related]
12. MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.
Pichler M; Ress AL; Winter E; Stiegelbauer V; Karbiener M; Schwarzenbacher D; Scheideler M; Ivan C; Jahn SW; Kiesslich T; Gerger A; Bauernhofer T; Calin GA; Hoefler G
Br J Cancer; 2014 Mar; 110(6):1614-21. PubMed ID: 24504363
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.
Liu J; Li H; Sun L; Shen S; Zhou Q; Yuan Y; Xing C
Dig Dis Sci; 2019 Jun; 64(6):1523-1534. PubMed ID: 30604369
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.
Ji D; Chen Z; Li M; Zhan T; Yao Y; Zhang Z; Xi J; Yan L; Gu J
Mol Cancer; 2014 Apr; 13():86. PubMed ID: 24755295
[TBL] [Abstract][Full Text] [Related]
15. AKT3 Expression in Mesenchymal Colorectal Cancer Cells Drives Growth and Is Associated with Epithelial-Mesenchymal Transition.
Buikhuisen JY; Gomez Barila PM; Torang A; Dekker D; de Jong JH; Cameron K; Vitale S; Stassi G; van Hooff SR; Castro MAA; Vermeulen L; Medema JP
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673003
[TBL] [Abstract][Full Text] [Related]
16. MiR-496 promotes migration and epithelial-mesenchymal transition by targeting RASSF6 in colorectal cancer.
Wang H; Yan B; Zhang P; Liu S; Li Q; Yang J; Yang F; Chen E
J Cell Physiol; 2020 Feb; 235(2):1469-1479. PubMed ID: 31273789
[TBL] [Abstract][Full Text] [Related]
17. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
18. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
[TBL] [Abstract][Full Text] [Related]
19. KCNQ1OT1/miR-217/ZEB1 feedback loop facilitates cell migration and epithelial-mesenchymal transition in colorectal cancer.
Bian Y; Gao G; Zhang Q; Qian H; Yu L; Yao N; Qian J; Liu B; Qian X
Cancer Biol Ther; 2019; 20(6):886-896. PubMed ID: 30794031
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
